help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Agthoven, T.
Right arrow Articles by Henzen-Logmans, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Agthoven, T.
Right arrow Articles by Henzen-Logmans, S. C.

American Journal of Pathology, Vol 144, 1238-1246, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry

T van Agthoven, M Timmermans, JA Foekens, LC Dorssers and SC Henzen-Logmans
Department of Molecular Biology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

Distribution of estrogen (ER), progesterone (PR) receptors, and epidermal growth factor (EGF) receptors was assayed by dual staining immunohistochemistry on 28 selected cytosolic ER-positive breast carcinomas and 22 nonmalignant breast tissues. ER-positive tumor cells were detected in 26 (93%) and EGF receptor positive tumor cells were detected in 7 (25%) carcinomas. In five tumors both ER and EGF receptors were detected but localized in distinct tumor cells. Only in one case of ductal carcinoma in situ co-expression was observed in a subset of tumor cells. In contrast, simultaneous expression of ER/PR and EGF receptors was observed in non-neoplastic ductal remnants in the majority of the carcinomas and the fibroadenomas. In addition, double- positive cells were occasionally detected in luminal epithelial cells of normal breast tissue and mastopathies. This study shows that ER/PR and EGF receptors in breast tumor cells are inversely related at the single cell level. However, demonstration of ER/PR and EGF receptors in individual normal luminal cells shows that expression is not mutually exclusive.


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
R. X-D Song, P. Fan, W. Yue, Y. Chen, and R. J Santen
Role of receptor complexes in the extranuclear actions of estrogen receptor {alpha} in breast cancer
Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S3 - S13.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. X.-D. Song and R. J. Santen
Membrane Initiated Estrogen Signaling in Breast Cancer
Biol Reprod, July 1, 2006; 75(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. Meijer, T. van Agthoven, P. T. Bosma, K. Nooter, and L. C.J. Dorssers
Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer Cells
Mol. Cancer Res., June 1, 2006; 4(6): 379 - 386.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M Lacroix, R-A Toillon, and G Leclercq
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. Rousseau, J. N. Nichol, F. Pettersson, M.-C. Couture, and W. H. Miller Jr.
ER{beta} Sensitizes Breast Cancer Cells to Retinoic Acid: Evidence of Transcriptional Crosstalk
Mol. Cancer Res., September 1, 2004; 2(9): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al.
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. S. Oh, L. A. Lorant, J. N. Holloway, D. L. Miller, F. G. Kern, and D. El-Ashry
Hyperactivation of MAPK Induces Loss of ER{alpha} Expression in Breast Cancer Cells
Mol. Endocrinol., August 1, 2001; 15(8): 1344 - 1359.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S L. Rosa, F Sessa, L Colombo, M G Tibiletti, D Furlan, and C Capella
Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas
J. Clin. Pathol., January 1, 2001; 54(1): 37 - 41.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. J. Fabian, B. F. Kimler, C. M. Zalles, J. R. Klemp, S. Kamel, S. Zeiger, and M. S. Mayo
Short-Term Breast Cancer Prediction by Random Periareolar Fine-Needle Aspiration Cytology and the Gail Risk Model
J Natl Cancer Inst, August 2, 2000; 92(15): 1217 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. W. Fuqua, C. Wiltschke, Q. X. Zhang, A. Borg, C. G. Castles, W. E. Friedrichs, T. Hopp, S. Hilsenbeck, S. Mohsin, P. O’Connell, et al.
A Hypersensitive Estrogen Receptor-{{alpha}} Mutation in Premalignant Breast Lesions
Cancer Res., August 1, 2000; 60(15): 4026 - 4029.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Orimo, S. Inoue, K. Ikeda, S. Noji, and M. Muramatsu
Molecular Cloning, Structure, and Expression of Mouse Estrogen-responsive Finger Protein Efp
J. Biol. Chem., October 13, 1995; 270(41): 24406 - 24413.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.